Published in Yeast on March 15, 2001
Adenosine kinase inhibition and suppression of RNA silencing by geminivirus AL2 and L2 proteins. J Virol (2005) 1.76
Life in the midst of scarcity: adaptations to nutrient availability in Saccharomyces cerevisiae. Curr Genet (2010) 1.65
Regulation of amino acid, nucleotide, and phosphate metabolism in Saccharomyces cerevisiae. Genetics (2012) 1.64
Viral genome methylation as an epigenetic defense against geminiviruses. J Virol (2008) 1.58
Adenosine kinase is inactivated by geminivirus AL2 and L2 proteins. Plant Cell (2003) 1.43
Adenosine kinase deficiency is associated with developmental abnormalities and reduced transmethylation. Plant Physiol (2002) 1.43
BSCTV C2 attenuates the degradation of SAMDC1 to suppress DNA methylation-mediated gene silencing in Arabidopsis. Plant Cell (2011) 1.18
A systematic high-throughput screen of a yeast deletion collection for mutants defective in PHO5 regulation. Genetics (2005) 1.16
Control of ATP homeostasis during the respiro-fermentative transition in yeast. Mol Syst Biol (2010) 1.13
The yeast ISN1 (YOR155c) gene encodes a new type of IMP-specific 5'-nucleotidase. BMC Biochem (2003) 0.95
Adenosine kinase of Trypanosoma brucei and its role in susceptibility to adenosine antimetabolites. Antimicrob Agents Chemother (2007) 0.94
YLR209c encodes Saccharomyces cerevisiae purine nucleoside phosphorylase. J Bacteriol (2001) 0.93
Physiological and toxic effects of purine intermediate 5-amino-4-imidazolecarboxamide ribonucleotide (AICAR) in yeast. J Biol Chem (2011) 0.90
The interaction between geminivirus pathogenicity proteins and adenosine kinase leads to increased expression of primary cytokinin-responsive genes. Virology (2010) 0.88
A complex containing SNF1-related kinase (SnRK1) and adenosine kinase in Arabidopsis. PLoS One (2014) 0.82
Cordycepin interferes with 3' end formation in yeast independently of its potential to terminate RNA chain elongation. RNA (2009) 0.82
Dissection of the PHO pathway in Schizosaccharomyces pombe using epistasis and the alternate repressor adenine. Curr Genet (2014) 0.82
Cordycepin in Schizosaccharomyces pombe: effects on the wild type and phenotypes of mutants resistant to the drug. Curr Genet (2003) 0.80
A chemical genetic strategy identify the PHOSTIN, a synthetic molecule that triggers phosphate starvation responses in Arabidopsis thaliana. New Phytol (2015) 0.79
Functional genomic analysis reveals overlapping and distinct features of chronologically long-lived yeast populations. Aging (Albany NY) (2015) 0.78
An adenosine kinase exists in Xanthomonas campestris pathovar campestris and is involved in extracellular polysaccharide production, cell motility, and virulence. J Bacteriol (2009) 0.77
Cytokinin Metabolism of Pathogenic Fungus Leptosphaeria maculans Involves Isopentenyltransferase, Adenosine Kinase and Cytokinin Oxidase/Dehydrogenase. Front Microbiol (2017) 0.75
Geographical prevalence of two types of Epstein-Barr virus. Virology (1986) 2.05
Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity (1998) 1.96
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses (1993) 1.67
Transcriptional regulation of the yeast gmp synthesis pathway by its end products. J Biol Chem (2001) 1.48
Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection. J Biol Chem (1999) 1.45
Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med (1991) 1.44
Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties. Virology (1998) 1.37
Yeast AMP pathway genes respond to adenine through regulated synthesis of a metabolic intermediate. Mol Cell Biol (2001) 1.33
The isolation and characterization of Saccharomyces cerevisiae mutants that constitutively express purine biosynthetic genes. Genetics (1997) 1.31
Separation of human lymphocytes forming spontaneous rosettes with sheep erythrocytes. Biomedicine (1973) 1.30
Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res (2001) 1.26
P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol (2000) 1.24
Role of the myb-like protein bas1p in Saccharomyces cerevisiae: a proteome analysis. Mol Microbiol (1998) 1.23
Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV). Int J Cancer (1975) 1.23
Synthesis of glutamine, glycine and 10-formyl tetrahydrofolate is coregulated with purine biosynthesis in Saccharomyces cerevisiae. Mol Gen Genet (1998) 1.22
The CCAAT box-binding factor stimulates ammonium assimilation in Saccharomyces cerevisiae, defining a new cross-pathway regulation between nitrogen and carbon metabolisms. J Bacteriol (1996) 1.19
Herpes simplex virus glycoprotein D: human monoclonal antibody produced by bone marrow cell line. Science (1983) 1.19
Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients. J Gen Virol (1987) 1.16
Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb (1993) 1.10
Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles. J Virol (1997) 1.07
Overexpression of P2Y2 purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb Vasc Biol (1997) 1.07
Nasopharyngeal carcinoma (NPC). I. Types of cultures derived from tumour biopsies and non-tumorous tissues of Chinese patients with special reference to lymphoblastoid transformation. Int J Cancer (1970) 1.06
Cloning of the ASN1 and ASN2 genes encoding asparagine synthetases in Saccharomyces cerevisiae: differential regulation by the CCAAT-box-binding factor. Mol Microbiol (1996) 1.05
The sequence of a 54.7 kb fragment of yeast chromosome XV reveals the presence of two tRNAs and 24 new open reading frames. Yeast (1997) 1.04
Proteome analysis and morphological studies reveal multiple effects of the immunosuppressive drug mycophenolic acid specifically resulting from guanylic nucleotide depletion. J Biol Chem (2001) 1.03
Lymphocytes in infectious mononucleosis. Properties of atypical cells and origin on the lymphoblastoid lines. Biomedicine (1973) 1.02
Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine. J Med Chem (1986) 1.01
Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase. Biochim Biophys Acta (1981) 1.00
Extracellular adenosine induces apoptosis of human arterial smooth muscle cells via A(2b)-purinoceptor. Circ Res (2000) 0.99
A genetic screen to isolate genes regulated by the yeast CCAAT-box binding protein Hap2p. Yeast (1994) 0.98
T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest (1986) 0.98
Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets. Biochem Pharmacol (1983) 0.97
Exogenous ATP induces a limited cell cycle progression of arterial smooth muscle cells. Am J Physiol (1993) 0.96
Yeast GMP kinase mutants constitutively express AMP biosynthesis genes by phenocopying a hypoxanthine-guanine phosphoribosyltransferase defect. Genetics (2000) 0.96
Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo. Nucleic Acids Res (1984) 0.96
Identification of genes affecting selenite toxicity and resistance in Saccharomyces cerevisiae. Mol Microbiol (2000) 0.96
Mutations in the yeast Myb-like protein Bas1p resulting in discrimination between promoters in vivo but notin vitro. Nucleic Acids Res (1998) 0.96
Persistence of human adenovirus 5 in human cord blood lymphoblastoid cell lines transformed by Epstein-Barr virus. Infect Immun (1980) 0.95
Evidence for diversity of Plasmodium falciparum sporozoite surface antigens derived from analysis of antibodies elicited in humans. Infect Immun (1990) 0.95
Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients. J Infect Dis (2000) 0.94
Monoclonal antibodies to HIV in a non-infected, immunised volunteer. Lancet (1988) 0.94
Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice. Cancer Res (1986) 0.94
Time course of osteopontin, osteocalcin, and osteonectin accumulation and calcification after acute vessel wall injury. J Histochem Cytochem (2001) 0.94
Isolation and characterization of the Saccharomyces cerevisiae XPT1 gene encoding xanthine phosphoribosyl transferase. J Bacteriol (1999) 0.93
YLR209c encodes Saccharomyces cerevisiae purine nucleoside phosphorylase. J Bacteriol (2001) 0.93
The human blood platelet: a cellular model to study the degradation of thymidine and its inhibition. Biochem Pharmacol (1982) 0.92
The nucleotide sequence of Saccharomyces cerevisiae chromosome XV. Nature (1997) 0.91
Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells. J Cell Physiol (1996) 0.91
Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins. J Pept Res (1998) 0.91
Presence of EBV-DNA sequences in nasopharyngeal cells of individuals without IgA-VCA antibodies. Int J Cancer (1983) 0.91
Signaling through regulated transcription factor interaction: mapping of a regulatory interaction domain in the Myb-related Bas1p. Nucleic Acids Res (2000) 0.89
Herpes simplex-RAJI(A44), a new cell line for serologic testing by immunofluorescence. J Immunol (1976) 0.88
In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes. Biomedicine (1976) 0.87
Enzymatic properties and inhibition by single-stranded autonomously replicating sequences of adenylosuccinate synthase from Saccharomyces cerevisiae. Eur J Biochem (1996) 0.86
APT1, but not APT2, codes for a functional adenine phosphoribosyltransferase in Saccharomyces cerevisiae. J Bacteriol (1999) 0.86
AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells. Circ Res (2003) 0.86
Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type 1 or coinfected with the two viruses. AIDS Res Hum Retroviruses (1995) 0.85
Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV. Scand J Immunol (1992) 0.85
Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis. Neurology (1998) 0.85
Establishment of human cell lines producing anti-D monoclonal antibodies: identification of Rhesus D antigen. Immunol Lett (1986) 0.84
Infectious mononucleosis-like response in common marmosets infected with Epstein-Barr virus. J Infect Dis (1984) 0.84
In vitro infection of epidermal Langerhans cells with human immunodeficiency virus type 1 (HTLV-IIIB isolate). Res Virol (1993) 0.84
In vitro analysis of complement-dependent HIV-1 cell infection using a model system. J Immunol (1999) 0.83
Redox regulation of AMP synthesis in yeast: a role of the Bas1p and Bas2p transcription factors. Mol Microbiol (2000) 0.83
Toxicity and activity of purified trichosanthin. AIDS (1991) 0.83
Molecular characterization of human monoclonal antibodies specific for several HIV proteins: analysis of the VH3 family expression. Immunol Lett (1996) 0.83
Epitope-tagging vectors designed for yeast. Curr Genet (1993) 0.83
Long terminal repeat sequence analysis of HTLV type I molecular variants identified in four north African patients. AIDS Res Hum Retroviruses (1994) 0.83
Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994. J Infect (1999) 0.83
Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I) Int J Cancer (1998) 0.82
Purification of human alpha 1 antiprotease-pancreatic elastase complex. Interaction with homologous elastin. Connect Tissue Res (1984) 0.82
ATP raises [Ca2+]i via different P2-receptor subtypes in freshly isolated and cultured aortic myocytes. Am J Physiol (1995) 0.82
Induction of cell cycle-dependent genes during cell cycle progression of arterial smooth muscle cells in culture. J Cell Physiol (1991) 0.82
The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction. Cell Mol Life Sci (2005) 0.82
Cell cycle dependent gene expression in quiescent stimulated and asynchronously cycling arterial smooth muscle cells in culture. J Cell Physiol (1992) 0.82
Transient adult T-cell leukemia/lymphoma picture during varicella infection in an HTLV-1 carrier. Leukemia (1994) 0.82
[Study of the extracellular macromolecular meshwork elaborated by rat aortic cells in secondary culture]. C R Seances Soc Biol Fil (1976) 0.81
Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides. J Gen Virol (2004) 0.81
Detection of HTLV-1 DNA by polymerase chain reaction in alveolar lymphocytes of patients with tropical spastic paraparesis. J Infect Dis (1989) 0.81
Mouse monoclonal antibodies directed against the HTLV-I protease recognize epitopes internal to the dimer. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.81
Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients. Int J Cancer (1977) 0.80
Highly conserved features of DNA binding between two divergent members of the Myb family of transcription factors. Nucleic Acids Res (2001) 0.80
Presence of HIV-1 subtypes B and F and HTLV-I in HIV/HTLV coinfected individuals of Martinique. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.80
Retroviral infection (HTLV-I) induces cytokine-regulated immunomodulation and cytotoxicity of medulloblastoma cells. J Neuropathol Exp Neurol (1995) 0.80
Further studies on the detection of the Epstein-Barr virus DNA in nasopharyngeal carcinoma biopsies from different parts of the world. IARC Sci Publ (1975) 0.80
In vitro HIV-1 entry and replication in Langerhans cells may clarify the HIV-1 genome detection by PCR in epidermis of seropositive patients. J Invest Dermatol (1992) 0.80
A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gp160-immunized healthy seronegative humans: evidence for persistent cell-mediated immunity. J Acquir Immune Defic Syndr (1992) 0.80
Human monoclonal antibodies with a protective activity against tetanus toxin. APMIS (1989) 0.80
Detection of Epstein-Barr viral DNA internal repeats in the nasopharyngeal mucosa of Chinese with IgA/EBV-specific antibodies. Int J Cancer (1982) 0.80
Biological markers associated with prolonged survival in African children maternally infected by the human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1992) 0.79
EBV specific secretory IgA in saliva of NPC patients. Presence of secretory piece in epithelial malignant cells. Int J Cancer (1977) 0.79
Production and characterization of a monoclonal antibody directed against HTLV-1 p19: use in a specific capture enzyme immunoassay. Hybridoma (1993) 0.79
Targeted expression of HTLV-I envelope proteins in muscle by DNA immunization of mice. Vaccine (2000) 0.78
Nuclear and mitochondrial revertants of a mitochondrial mutant with a defect in the ATP synthetase complex. Mol Gen Genet (1987) 0.78